We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Port Erin | LSE:PEBI | London | Ordinary Share | IM00B6QH1J21 | ORD 0.0001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.50 | 4.00 | 5.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
29/3/2017 10:58 | Yep, it seems like the wait continues for concrete action, whether by PEBI to reduce the discount or one of the portfolio investees to surge. Or for a press mention of the 40% discount to NAV :o)) FYI Northland have updated as follows today: "Northland Capital partners view: PEBI reported a strong gain in its Net Asset Value, up 20% YoY. Nevertheless, there is significant upside to the Company’s shares, as the Group’s market valuation still remains at a c. 50% discount to the underlying asset base. The Company's investments continue to show significant potential. Of note, Northland’s price target on one of PEBI’s portfolio holdings, namely SalvaRx, is 149p, while SalvaRx’s current share price is 30p. We also see significant upside to several other PEBI holdings." | rivaldo | |
29/3/2017 09:39 | Hi Rivaldo,Yes, it's good to see recognition of the discount issue, though action is more elusive.....Also interesting to see a little more info on the unquoted side with Luminor and SavaRx, those two plus DBC/Pulse-flow is where the cash from SUMM and Magna sales has been reinvested.By now I was expecting to see more on DBC reversing into LIFE; the clock is ticking!Cheers, tightfist | tightfist | |
29/3/2017 08:35 | Final results out today - NAV of 11.13p per share. The share price discount is described as "significant and disappointing", with "a number of options" being considered. It's decision time for DBC with PEBI's loan being due for repayment by 31st March. | rivaldo | |
27/3/2017 21:46 | It seems to me that PEBI has entered a complete backwater within the Mellon camp, it is getting minimal attention? I was hoping that Mellon would want to close it with a respectable result, to keep his record clean? The talk of closing the discount has come to nothing, after Tranche 1 in Autumn 2015. | tightfist | |
26/3/2017 09:53 | Nobody on the PEBI stand at Master Investor yesterday. Shabby. | snape | |
09/3/2017 19:11 | Hi Rivaldo,I reckon the NAV stands at about 11.3p. IIRC the DBC loan has to be settled by end March? I wonder how the IPO us shaping-up.Cheers, tightfist | tightfist | |
01/3/2017 12:37 | Both Magna and Regent Pacific continue to do well, and SUMM is also climbing. The next NAV announcement should be interesting. | rivaldo | |
15/2/2017 11:56 | The NAV looks to be up at around 11.4p and the discount back up to around 47%. Some things never change! tightfist | tightfist | |
12/1/2017 07:37 | This explains the interest ! NAV of 11.13 pence Pacific group doing well. RNS Number : 9529T Port Erin Biopharma Investments Ltd 12 January 2017 Port Erin Biopharma Investments Limited (the "Company") Net Asset Value calculation to 31 December 2016 Jim Mellon, Chairman, commented: - "The Net Asset Value ("NAV") calculation for the Company as at closing on 31 December 2016 was 11.13 pence per share, including un-invested cash of GBP66,642. The portfolio is valued under IFRS at bid price. Net Assets stand at GBP2.62 million including investments of GBP2.55 million. This quarter's NAV represents an increase of 11.7% from the previous valuation of 9.96 pence per share, which included un-invested cash of GBP12,921. No management fee is due to Shellbay Investments Limited. The increase in reported NAV to 31 December 2016 is mainly due to an upturn in the value of the holding in Regent Pacific Group. The Company's three principal investments continue to show significant growth potential during 2017 and beyond". Unaudited to 31 December 2016 GBP Fixed Assets Investments 2,548,237 Current Assets Sundry Debtors 8,592 Uninvested cash 66,642 Current Liabilities Creditors: amounts due (41,962) -------------------- 2,581,509 Capital and Reserves Share Capital 23 Share Premium 1,890,142 Reserves 691,344 -------------------- 2,581,509 Shares in Issue 23,195,558 Net Asset Value per share 11.13 pence Portfolio Details Investments as at 31 Value % of Total Portfolio December 2016 -------------------- Magna Biopharma Income Fund GBP953,318 37.41% Regent Pacific Group GBP740,148 29.05% Summit Corporation GBP170,706 6.70% Investment loans GBP200,000 7.85% Other quoted holdings GBP136,845 5.37% Other unquoted holdings GBP347,220 13.62% Total GBP2,548,237 100.00% -------------------- For further information, please contact: Port Erin Biopharma Northland Capital Partners Peterhouse Capital Investments Limited Limited Limited The Company Nomad and Broker Broker Denham Eke Matthew Johnson / David Lucy Williams (+44) (0) 1624 639396 Hignell (+44) (0) 207 (+44) (0) 203 861 6625 469 0936 This information is provided by RNS | glyn10 | |
11/1/2017 17:50 | I am guessing the 489,343 shares was a buy at 8p? Mega volume, PI or Insti? | glyn10 | |
04/1/2017 14:32 | Why are the sellers not using the auction book process | hindsight | |
29/12/2016 13:18 | Re pebi results out other day, bad is no mention of discount control this time and the 200k professional fees a big issue, costs jm 30%, 65k of that good is luminor and diabetic shoe company if hype true | hindsight | |
29/12/2016 12:51 | not a good sign that JM may be using this vehicle to make loans to other companies he has an interest in ie recent loan from pebi to DBC i'm invested in DBC which is reversing in to a listed company currently in suspension | kristini2 | |
16/12/2016 15:44 | Would anyone like to do a spreadsheet swap, ie see if they tally and if not why not ? | hindsight | |
29/11/2016 12:19 | and getting better ! | glyn10 | |
29/11/2016 08:23 | Nice start :o)) | rivaldo | |
25/11/2016 07:41 | Regent Pacific up almost another 20% to 0.72 overnight in HK.... | rivaldo | |
24/11/2016 08:28 | Moving nicely again. Still trading at a huge discount to NAV though. Thx again tightfist. | rivaldo | |
23/11/2016 11:46 | Tightfist, I've sent you a PM as requested. I've also updated the thread header. ADVFN's m/cap seems wrong as there's only 23.2m shares in issue - it s/be only £1.45m at 6.25p. The other side of your post is that there's 100% upside from here to the current NAV - and more with Diabetic Boot about to hopefully IPO. | rivaldo | |
23/11/2016 09:33 | Hi Rivaldo,Apologies that I missed your postings over the last few weeks. Looking just at RP(PLE), Magna and SUMM (ignoring any value shifts in the Other categories) I estimate the NAV this morning at £2,827m or 12.2p and the current discount 51% where it seems to be stubbornly stuck!I see no further RNS news on Diabetic Boot reversing into Life Science Dev. - that could provide a useful uplift.Cheers, tightfistPS: Please send me a private message if you would like to see and check! my spreadsheet. | tightfist | |
23/11/2016 08:25 | Regent Pacific was up another 20% overnight to 0.61, so PEBI's holding must be worth around £0.6m now - double the £0.3m at 30th June. For the record, here's the portfolio at 30th June - I'll amend the thread header at some point: Investments as at 30 June 2016 Value % of Total Portfolio Magna Biopharma Income Fund £1,312,807 56.4% Regent Pacific Group £302,568 12.9% Summit Corporation £197,513 8.5% Other quoted holdings £114,716 4.9% Other unquoted holdings £401,964 17.3% Total £2,329,568 100.0% | rivaldo | |
21/11/2016 14:20 | The prior post was complete rubbish, so I've edited it... PEBI's holding in Regent Pacific was worth £250,000 at 30/6/16, and it's gone up from 0.22 at that date to 0.5 today, so this holding is probably now worth well over £500,000: Tightfist, I'd love to see your updated NAV spreadsheet if possible :o)) | rivaldo | |
15/11/2016 14:01 | Hi tightfist. Nice 50k buy has moved the price up today. Good to see SUMM holding nicely up at 180p+. Can you clarify for me the worth of the holding in PLE? I know they're now in JM's company Regent Pacific (0575) - are you aware of how many shares or whatever PEBI own in that entity? | rivaldo |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions